Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Coronavirus pandemic puts UK’s post-Brexit drug stockpile at risk

June 8, 2020 Sales and Marketing COVID-19, coronavirus, drugs

The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …
News
stacey

Stacey Coen appointed Senior Vice President and Chief Business Officer at ImmunoGen

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …
Appointment
remdesivir_ulrich_perrey

Australian Taskforce recommends Gilead’s remdesivir for routine use in the country’s COVID-19 patients

June 5, 2020 Medical Communications, Sales and Marketing Australia, COVID-19, Gilead, coronavirus, remdesivir

Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …
News
remdesivir_ulrich_perrey

India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020 Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
News

Sanofi’s Sarclisa combo approved in Europe for relapsed/refractory multiple myeloma

June 2, 2020 Manufacturing and Production, Sales and Marketing Europe, Sanofi, Sarclisa, pharma

Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in …
News
ipsen

Ipsen appoints David Loew as new Chief Executive Officer

June 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

David Loew will leave his position as the head of Sanofi’s vaccine division to become the Chief Executive Officer of …
Appointment

How Big Brother is helping to fight COVID-19

June 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace

Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …
Feature
putey

Russia to begin administering anti-viral COVID-19 drug next week

June 1, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Russia, coronavirus, pandemic, virus

Russia will start its roll out of the anti-viral drug Avifavir (favipiravir) to COVID-19 patients next week, according to the …
News
gilead-sciences

Gilead’s magrolimab shows promising responses in untreated myelodysplastic syndrome and acute myeloid leukaemia at ASCO 2020

June 1, 2020 Research and Development, Sales and Marketing ASCO 2020, Cancer, Gilead, leukaemia, magrolimab

Gilead took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to unveil new Phase 1b …
News
clinical_trials

Significant lack of women and minorities involved in clinical trials for cardiometabolic medication, research shows

June 1, 2020 Sales and Marketing cardio, cardiovascular, cvd

Women and minorities, particularly African Americans, continue to be under represented in clinical trials for cardiometabolic medication, according to a …
News
lynparza

Lynparza secures CHMP recommendation in first-line BRCA-mutated metastatic pancreatic cancer

June 1, 2020 Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza

Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has just secured recommendation for approval from the European Medicines …
News

US donates $1 billion to Oxford University’s COVID-19 vaccine in exchange for 300 million doses

June 1, 2020 Sales and Marketing COVID-19, coronavirus

The US has given $1 billion to AstraZeneca to advance the development and production of the vaccine they are creating …
News
bmssyracuseny

BMS’ Zeposia becomes first S1P receptor modulator available in Europe for relapsing remitting multiple sclerosis

May 28, 2020 Sales and Marketing Avonex, Bristol-Myers Squibb, EU, Europe, Zeposia, bristol myers squibb, multiple sclerosis

Bristol Myers Squibb is celebrating after its oral therapy Zeposia (ozanimod), secured European Commission for the treatment of relapsing remitting …
News
martin_andrews

Evox appoints ex-GSK exec Martin Andrews as new non-Executive Director

May 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evox, GSK, appointment

Evox Therapeutics has named ex-GlaxoSmithKline executive Martin Andrews as its new non-Executive Director, it has emerged.   Andrews has previously …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026